Sanofi has scored FDA approval for its subcutaneous version of Sarclisa, giving the multiple myeloma...
Sanofi snags FDA thumbs up for Sarclisa as 1st cancer drug delivered by on-body injector
Sanofi has scored FDA approval for its subcutaneous version of Sarclisa, giving the multiple myeloma treatment a potential boost in its competition with...
Author: Fierce Pharma
Read Original Article